REMDESIVIR REPLICA MANUFACTURED IN INDIA TO TREAT COVID – 19 PATIENTS IN ICU

0
187

A generic version of the FDA approved drug, Remdesivir manufactured in India is now being administered to COVID-19 patients in the Intensive Care Unit. Temika Rodney reports.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.